Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption

被引:144
作者
Inui, T
Ishibashi, O
Inaoka, T
Origane, Y
Kumegawa, M
Kokubo, T
Yamamura, T
机构
[1] CIBA GEIGY LTD,INT RES LABS,TAKARAZUKA,HYOGO 665,JAPAN
[2] MEIKAI UNIV,SCH DENT,DEPT ORAL ANAT,SAKADO,SAITAMA 35002,JAPAN
关键词
D O I
10.1074/jbc.272.13.8109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cathepsin K is a recently identified cysteine protease which is abundantly and selectively expressed in osteoclasts, To evaluate the contribution of cathepsin K to bone resorption processes, we investigated the effect of cathepsin K antisense phosphothiorate oligodeoxynucleotide (S-ODN) on the bone-resorbing activity of osteoclasts. Rabbit osteoclasts were cultured on dentine slices for 24 h in the presence or absence of antisense S-ODN in a medium containing 100 nM Tfx(TM)-50, polycationic liposome, as a carrier of the S-ODN, Uptake of the S-ODN by osteoclasts was confirmed microscopically using fluorescein-labeled S-ODN, The treatment with antisense significantly decreased the amount of cathepsin K protein in osteoclasts. The antisense inhibited the osteoclastic pit formation in a concentration-dependent fashion, At 10 mu M the antisense reduced the total pit number and area and average pit depth by 46, 52, and 30%, respectively, The sense and mismatch S-ODNs, which were used as negative controls, had no effect on either the cathepsin K protein level or the pit formation. A nonspecific cysteine protease inhibitor, E-64, also reduced pit formation in a concentration-dependent manner with maximum reductions at 1 mu M of 46, 48, and 35% in the above pit parameters, The inhibitory effect of the antisense almost equal to that of E-64 demonstrates that cathepsin K is a cysteine protease playing a crucial role in osteoclastic bone resorption.
引用
收藏
页码:8109 / 8112
页数:4
相关论文
共 30 条
[1]   CELL-MEDIATED EXTRACELLULAR ACIDIFICATION AND BONE-RESORPTION - EVIDENCE FOR A LOW PH IN RESORBING LACUNAE AND LOCALIZATION OF A 100-KD LYSOSOMAL MEMBRANE-PROTEIN AT THE OSTEOCLAST RUFFLED BORDER [J].
BARON, R ;
NEFF, L ;
LOUVARD, D ;
COURTOY, PJ .
JOURNAL OF CELL BIOLOGY, 1985, 101 (06) :2210-2222
[2]   Proteolytic activity of human osteoclast cathepsin K - Expression, purification, activation, and substrate identification [J].
Bossard, MJ ;
Tomaszek, TA ;
Thompson, SK ;
Amegadzie, BY ;
Hanning, CR ;
Jones, C ;
Kurdyla, JT ;
McNulty, DE ;
Drake, FH ;
Gowen, M ;
Levy, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12517-12524
[3]   Human cathepsin O-2, a matrix protein-degrading cysteine protease expressed in osteoclasts - Functional expression of human cathepsin O-2 in Spodoptera frugiperda and characterization of the enzyme [J].
Bromme, D ;
Okamoto, K ;
Wang, BB ;
Biroc, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2126-2132
[4]   HUMAN CATHEPSIN O2, A NOVEL CYSTEINE PROTEASE HIGHLY EXPRESSED IN OSTEOCLASTOMAS AND OVARY MOLECULAR-CLONING, SEQUENCING AND TISSUE DISTRIBUTION [J].
BROMME, D ;
OKAMOTO, K .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1995, 376 (06) :379-384
[5]  
Delaisse Jean-Marie, 1992, P289
[6]   INHIBITION OF BONE-RESORPTION IN CULTURE BY INHIBITORS OF THIOL PROTEINASES [J].
DELAISSE, JM ;
EECKHOUT, Y ;
VAES, G .
BIOCHEMICAL JOURNAL, 1980, 192 (01) :365-368
[7]   THE EFFECTS OF INHIBITORS OF CYSTEINE-PROTEINASES AND COLLAGENASE ON THE RESORPTIVE ACTIVITY OF ISOLATED OSTEOCLASTS [J].
DELAISSE, JM ;
BOYDE, A ;
MACONNACHIE, E ;
ALI, NN ;
SEAR, CHJ ;
EECKHOUT, Y ;
VAES, G ;
JONES, SJ .
BONE, 1987, 8 (05) :305-313
[8]   INVIVO AND INVITRO EVIDENCE FOR THE INVOLVEMENT OF CYSTEINE PROTEINASES IN BONE-RESORPTION [J].
DELAISSE, JM ;
EECKHOUT, Y ;
VAES, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 125 (02) :441-447
[9]  
DELAISSE JM, 1986, CYSTEINE PROTEINASES, P259
[10]   Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts [J].
Drake, FH ;
Dodds, RA ;
James, IE ;
Connor, JR ;
Debouck, C ;
Richardson, S ;
LeeRykaczewski, E ;
Coleman, L ;
Rieman, D ;
Barthlow, R ;
Hastings, G ;
Gowen, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12511-12516